NOREXAPEPTIDES
HomeProductsCategoriesCalculatorVerifyContactBasket (0)
NOREXA Semax 10 mg Lyophilized Peptide vial — Research Use Only

Product images are for illustrative reference only. Final label layout and packaging details may vary by batch or production run. Product identity, strength and batch-specific documentation are provided separately and remain product-specific.

NOREXA PEPTIDES / RESEARCH MATERIAL

Semax10 mg

Lyophilized Peptide — Single vial

Semax 10 mg supplied exclusively as a laboratory research material. Available batch documentation is published only under its corresponding batch record.

Out of stock
Pricing confirmed separately
RESEARCH FOCUS
Brain & Cognition
QUANTITY
Research areas
Nootropic Research
FOR LABORATORY RESEARCH USE ONLY.

Not for human or animal consumption.
Not intended to diagnose, treat, cure or prevent any disease.

VERIFY BATCH →
Semax · 10 mg—RESEARCH & TECHNICAL OVERVIEW

RESEARCH & TECHNICAL OVERVIEW

Semax
10 mg

Semax is a synthetic heptapeptide derived from the ACTH(4–7) sequence and extended with Pro-Gly-Pro. The intact heptapeptide is synthetic rather than a naturally occurring hormone.

Published research has examined neurotrophin-related signalling, gene-expression responses and experimental cerebral-ischaemia models. The evidence includes cellular and animal work, with a smaller body of human research.

RESEARCH SCOPE

For research use only. Not for human or veterinary use. Published findings describe the compound or related research systems; they are not claims about this NOREXA batch.

HANDLING INFORMATION

Storage After
Reconstitution.

Temperature
Refrigerate at 2–8°C.
Light
Keep sealed and protected from light.
Stability
An exact post-reconstitution stability period has not been established for this formulation.

An exact post-reconstitution storage period has not been established for this formulation.

MedChemExpress — Semax technical record ↗

SCIENTIFIC CONTEXT

Structured.
Source-led.

Longer technical information is grouped for easier reading on desktop and mobile.

01Natural Biological Context+

Semax is structurally related to a fragment of adrenocorticotropic hormone (ACTH), an endogenous peptide hormone. The Pro-Gly-Pro extension creates a distinct synthetic research compound.

The current NOREXA record names Semax but does not publish a counter-ion or supplier-confirmed salt form.

02Research Mechanisms+
Preclinical

Neurotrophin-related signalling

Astrocyte and animal studies have examined BDNF-related responses following Semax exposure.

Preclinical

Transcriptomic response

Rat focal-ischaemia studies reported changes in immune- and vascular-system gene expression.

Preclinical

Stress-response proteins

Protein-expression studies in rat brain models have examined CREB, JNK, c-Fos and MMP-9 responses.

03Research Applications+
  • Neurotrophin and synaptic-plasticity pathway research.
  • Transcriptomic analysis in experimental neural-stress models.
  • Preclinical immune, vascular and cell-stress signalling studies.
04Laboratory Research Preparation+

Lyophilized material may require preparation as a laboratory solution before use in an in-vitro assay. The solvent or buffer and working concentration should follow the applicable protocol and documentation for the exact molecular form.

This page intentionally provides no human dosing calculations, syringe-unit conversions, administration route or treatment schedule. Preparation conditions should be established and recorded by qualified laboratory personnel.

INDEPENDENT VERIFICATION

Batch evidence,
without overclaiming.

Purity alone is not enough. NOREXA distinguishes identity, purity and actual quantity, and publishes results only for the exact batch tested.

CURRENT BATCH / LOT

Independent batch verification: report not currently published

No identity, purity, quantity or batch number is shown as independently verified until exact product-and-lot evidence is available.

OPEN CENTRAL BATCH VERIFICATION →

HISTORICAL BATCHES

No historical batch records are currently published for this product.

PRODUCT INFORMATION

Technical
Data.

Verified identity and catalogue information for this NOREXA research material. Unconfirmed fields are omitted.

Product Name
Semax
Content
10 mg
Form
Lyophilized Peptide
Presentation
Single vial
CAS Number
80714-61-0
Synonym
ACTH(4-7)-Pro-Gly-Pro
Peptide Sequence
MEHFPGP
Molecular Formula
C37H51N9O10S
Molecular Weight
813.9 g/mol
Research Classification
Research Use Only

Batch documentation and independent reports are shown only when published for the exact corresponding batch.

CHEMICAL IDENTITY REFERENCE ↗

SELECTED SOURCES

Research
Literature.

Selected literature describes the compound and relevant research pathways; it does not constitute testing or endorsement of this NOREXA batch.

  1. 01
    Preclinical

    Semax, an analogue of adrenocorticotropin (4–10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain

    Journal of Neurochemistry · 2006

    ↗
  2. 02
    Preclinical

    The peptide Semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia

    BMC Genomics · 2014

    ↗
  3. 03
    Preclinical

    Brain Protein Expression Profile Confirms the Protective Effect of Semax in a Rat Model

    International Journal of Molecular Sciences · 2021

    ↗

PRODUCT FAQ

Semax
questions.

01Is Semax naturally occurring?+

No. It is a synthetic peptide based on an ACTH fragment and extended with Pro-Gly-Pro.

02What form is identified in the product record?+

The public record identifies CAS 80714-61-0, formula C37H51N9O10S and the MEHFPGP sequence. No acetate or other counter-ion is assumed.

03What research areas are represented?+

The selected literature covers neurotrophin-related responses, transcriptomics and experimental neural-stress models.

04What storage statement is shown?+

Only the aqueous laboratory-stock condition for a reference matching the displayed CAS number, formula and sequence. No bacteriostatic-water refrigerator period is inferred.

SECTION 01 — STANDARDS

Scientific transparency,
documented for research.

01 / 03

Scientific Integrity

Independent analytical results are presented as reported by the testing laboratory, without altering the laboratory’s findings.

02 / 03

Batch Traceability

Each batch is assigned a record linking the product to its available technical and independent testing documentation.

03 / 03

Quality Documentation

Available batch documentation is organized under the corresponding batch number for clear reference.

NOREXA PEPTIDES · BIOTECH RESEARCH

RESEARCH USE ONLY
NOT FOR HUMAN OR VETERINARY USE

SITE MAPPRODUCTSCATEGORIESCALCULATORVERIFYRESEARCH PEPTIDES EUROPEPEPTIDES AND AMINO ACIDSCONTACTTERMSPRIVACYRESEARCH USE DISCLAIMER
CONTACTSUPPORT@NOREXAPEPTIDES.COM

Research Use Only. Products are supplied solely for laboratory research and analytical purposes.

© 2026 NOREXA PEPTIDES · ALL RIGHTS RESERVED
TGTelegram: @norexapeptidesWAWhatsApp: +44 7346 714593

NOREXA PEPTIDES

RESEARCH ACCESS

Welcome

Please confirm before entering the website.

Are you 18 years or older?

RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE